Latest period
$0.00
YoY change
—
5Y CAGR
—
Peak year (2013)
$15.85M
Cumulative CapEx
$32.17M
CapEx history chart for SELLAS Life Sciences Group (SLS) from 2006 to 2025
Latest: $0.00
CapEx growth chart for SELLAS Life Sciences Group (SLS) from 2006 to 2025
Latest: -100.0%
CapEx history table for SELLAS Life Sciences Group (SLS) from 2006 to 2025
| 2025 | $0.00 | — | $0.00 | ||
| 2024 | $0.00 | -100.0% | −$5.50M | ||
| 2023 | $5.50M | +22.2% | +$1.00M | ||
| 2022 | $4.50M | — | +$4.50M | ||
| 2021 | $0.00 | — | $0.00 | ||
| 2020 | $0.00 | — | $0.00 | ||
| 2019 | $0.00 | — | $0.00 | ||
| 2018 | $0.00 | — | $0.00 | ||
| 2017 | $0.00 | -100.0% | −$6.00K | ||
| 2016 | $6.00K | -96.1% | −$147.00K | ||
| 2015 | $153.00K | -97.2% | −$5.38M | ||
| 2014 | $5.53M | -65.1% | −$10.32M | ||
| 2013 | $15.85M | — | +$15.85M | ||
| 2012 | $0.00 | -100.0% | −$53.00K | ||
| 2011 | $53.00K | -50.0% | −$53.00K | ||
| 2010 | $106.00K | +27.7% | +$23.00K | ||
| 2009 | $83.00K | -50.0% | −$83.00K | ||
| 2008 | $166.00K | -27.5% | −$63.00K | ||
| 2007 | $229.00K | — | +$229.00K | ||
| 2006 | $0.00 | — | — |
- 2025$0.00—
- 2024$0.00-100.0%
- 2023$5.50M+22.2%
- 2022$4.50M—
- 2021$0.00—
- 2020$0.00—
- 2019$0.00—
- 2018$0.00—
- 2017$0.00-100.0%
- 2016$6.00K-96.1%
- 2015$153.00K-97.2%
- 2014$5.53M-65.1%
- 2013$15.85M—
- 2012$0.00-100.0%
- 2011$53.00K-50.0%
- 2010$106.00K+27.7%
- 2009$83.00K-50.0%
- 2008$166.00K-27.5%
- 2007$229.00K—
- 2006$0.00—
CapEx values are taken from SELLAS Life Sciences Group's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at SELLAS Life Sciences Group (SLS)
According to SELLAS Life Sciences Group's latest reported financial statements, the company's current CapEx (TTM) is $0.00. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of SELLAS Life Sciences Group (SLS) CapEx is $0.00.
SELLAS Life Sciences Group CapEx compound annual growth for the 2015–2025 (10 years) window is -100.0%, with a net decline across the window.
SELLAS Life Sciences Group CapEx peaked at $15.85M in 2013; the latest annual figure is $0.00 in 2025 (100.0% below peak).
The record annual CapEx stands at $15.85M, reached in 2013; the historical low of $0.00 was recorded in 2006.
SELLAS Life Sciences Group Capital Expenditures by Year
SELLAS Life Sciences Group Capital Expenditures 2025: $0.00
SELLAS Life Sciences Group CapEx in 2025 was $0.00.
SELLAS Life Sciences Group Capital Expenditures 2024: $0.00
2024's CapEx for SELLAS Life Sciences Group came in at $0.00, plunged 100.0% below 2023.
SELLAS Life Sciences Group Capital Expenditures 2023: $5.50M
SELLAS Life Sciences Group posted CapEx of $5.50M in 2023, grew 22.2% from 2022.
SELLAS Life Sciences Group Capital Expenditures 2022: $4.50M
SELLAS Life Sciences Group CapEx in 2022 was $4.50M.
SELLAS Life Sciences Group Capital Expenditures 2021: $0.00
SELLAS Life Sciences Group CapEx in 2021 was $0.00.
See more financial history for SELLAS Life Sciences Group (SLS).
Sector peers by CapEx
Healthcare peers of SELLAS Life Sciences Group (SLS), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
SELLAS Life Sciences Group (SLS) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation